The Diagnostic Protocol of the EuroEspes International Centre for Neuroscience and Genomic Medicine includes multiple customised tests adapted to the needs of each patient. Our priority is to protect and strengthen the health of our patients.
The International Centre for Neuroscience and Genomic Medicine specifically addresses the main pathologies affecting the Central Nervous System with personalised action protocols for:
Neurodegenerative diseases: Alzheimer's disease, other dementias, Parkinson's disease and other movement disorders.
Other diseases that affect the functioning of the Central Nervous System: migraines, headaches, dizziness, dizziness.
1. MEDICAL EXAMINATION
General
Systemic
Neurological
Psychiatric
2. LABORATORY ANALYSIS
Analysis of blood (biochemistry, blood count, metabolism, hormones), urine and other body fluids
Special Tests: Neurotransmitters, Tumour Markers, Customised Panels, Food Intolerances
3. IMAGING TESTS
Radiology
Densitometry
Magnetic Resonance Imaging
Computed Axial Tomography
4. DIGITAL DIAGNOSTIC TESTS
Brain Mapping
Digital Optical Surveying
Ultrasonography
Electrophysiology
Specific Somatosensory Tests by Sense Organs (Vision, Hearing, Smell, Taste, Touch)
Psychomotor tests
5. Neuropsychological and Psychometric Assessment
Cognitive Function
Emotional Status
Conduct
Intelligence
Psychomotricity
6. GENOMIC DIAGNOSIS
Global exome (NGS technology)
Specific Diagnostic Panels: Predictive Genomics, Diagnostic Genomics
Monogenic Genetic Analysis
7. Pharmacogenetic Profile
Global (PGx-60/4000)
By Pathology
By Pharmacological Category
By Drug
8. Epigenetic Biomarkers
Global DNA methylation
Expression of Pathogenic Genes
Expression of FarmaGenes (PharmacoEpiGenetics)
9. Comprehensive Medical Report
Includes all the tests in the diagnostic process and the treatment guidelines to follow based on the patient's pharmacogenetic profile.
10. Smart Pharmacogenetics Card
Bioinformatics tool with the Global Pharmacogenetic Profile that allows patients and their doctors, in any speciality, to establish personalised treatment guidelines for life.
The Smart Pharmacogenetic Card has two formats:
Physical card with USB accessibility for personalisation of treatment + comprehensive medical history (with all tests accessible)
Virtual card with accessibility through digital media via the internet (mobile phones, tablets, computers).